The average one-year price target for Werewolf Therapeutics (NasdaqGS:HOWL) has been revised to $6.38 / share. This is an ...
Werewolf Therapeutics, Inc. (HOWL) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...
Thinking about watching 'Howl of the Werewolf' at home? Pinpointing where to stream, rent, buy, or watch how to watch the Alice Maio Mackay directed movie can be confusing so we at Moviefone are here ...
On December 18, 2025, Werewolf Therapeutics, Inc. (NASDAQ:HOWL) shared a comprehensive pipeline update in which it highlighted clinical progress and 2026 priorities for its INDUKINE programs and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results